Benzonaphthyridinamines as autotaxin inhibitors
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to benzonaphthyridinamines of the formula (I) as autotaxin inhibitors and to the use thereof in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in which the inhibition, regulation and/or modulation of phosphodiesterase or lysophospholipase autotaxin plays a role, in particular of various types of cancer and autoimmune and inflammatory diseases.
-
Citations
11 Claims
- 1. A compound of formula (I)
Specification